Who makes [18F]-JNJ-70099731?

[18F]-JNJ-70099731 is developed by Janssen Research & Development, LLC.

What development phase is [18F]-JNJ-70099731 in?

[18F]-JNJ-70099731 is in Phase 1.

Last reviewed 2026-05-14 · How we verify

[18F]-JNJ-70099731

Janssen Research & Development, LLC · Phase 1 active Small molecule

At a glance

Generic name	[18F]-JNJ-70099731
Sponsor	Janssen Research & Development, LLC
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F]-JNJ-70099731 CI brief — competitive landscape report
[18F]-JNJ-70099731 updates RSS · CI watch RSS
Janssen Research & Development, LLC portfolio CI